Evidence map›Paper›PMID 24462047›Full record

ArticleNutrition, metabolism, and cardiovascular diseases : NMCD2014

Increased density of inhibitory noradrenergic parenchymal nerve fibers in hypertrophic islets of Langerhans of obese mice.

I Giannulis, E Mondini, F Cinti, A Frontini, I Murano, R Barazzoni, G Barbatelli, D Accili, S Cinti

Abstract read
In one paragraph

Article in Nutrition, metabolism, and cardiovascular diseases : NMCD, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. From Obesity to Diabetes: The Role of the Adipose Organ.Handbook of experimental pharmacology · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

I GiannulisDpt of Experimental and Clinical Medicine, Obesity Center, University of Ancona (Politecnica delle Marche) and Azienda Ospedali Riuniti, 60020 Ancona, Italy.
E MondiniDpt of Experimental and Clinical Medicine, Obesity Center, University of Ancona (Politecnica delle Marche) and Azienda Ospedali Riuniti, 60020 Ancona, Italy.
F CintiDpt of Experimental and Clinical Medicine, Obesity Center, University of Ancona (Politecnica delle Marche) and Azienda Ospedali Riuniti, 60020 Ancona, Italy.
A FrontiniDpt of Experimental and Clinical Medicine, Obesity Center, University of Ancona (Politecnica delle Marche) and Azienda Ospedali Riuniti, 60020 Ancona, Italy.
I MuranoDpt of Experimental and Clinical Medicine, Obesity Center, University of Ancona (Politecnica delle Marche) and Azienda Ospedali Riuniti, 60020 Ancona, Italy.
R BarazzoniDpt of Medical, Surgical and Health Sciences, Clinical Medicine, University of Trieste, Trieste, Italy.
G BarbatelliDpt of Experimental and Clinical Medicine, Obesity Center, University of Ancona (Politecnica delle Marche) and Azienda Ospedali Riuniti, 60020 Ancona, Italy.
D AcciliNaomi Berrie Diabetes Center, Dpt of Medicine, College of Physicians & Surgeons of Columbia University, New York, NY 10032, USA. Electronic address: da230@columbia.edu.
S CintiDpt of Experimental and Clinical Medicine, Obesity Center, University of Ancona (Politecnica delle Marche) and Azienda Ospedali Riuniti, 60020 Ancona, Italy. Electronic address: s.cinti@univpm.it.
Columbia University · USUniversity of Trieste · IT

Funding

MECHANISMS OF BETA CELL FAILURER01DK064819 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ACCILI, DOMENICO · 2003 to 2025
$10.5M
NIDDK NIH HHS R01 DK064819
6 · The paper itself

Abstract

BACKGROUND AND

aimWe sought to identify mechanisms of beta cell failure in genetically obese mice. Little is known about the role of pancreatic innervation in the progression of beta cell failure. In this work we studied adrenergic innervation, in view of its potent inhibitory effect on insulin secretion. We analyzed genetically obese ob/ob and db/db mice at different ages (6- and 15-week-old), corresponding to different compensatory stages in the course of beta cell dysfunction. 15 week-old HFD mice were also studied. METHODS AND

resultsAll mice were characterized by measures of plasma glucose, insulin, and HOMA. After perfusion, pancreata were dissected and studied by light microscopy, electron microscopy, and morphometry. Insulin, Tyrosine Hydroxylase-positive fibers and cells and Neuropeptide Y-positive cells were scored by immunohistochemistry. Islets of obese mice showed increased noradrenergic fiber innervation, with significant increases of synaptoid structures contacting beta cells compared to controls. Noradrenergic innervation of the endocrine area in obese db/db mice tended to increase with age, as diabetes progressed. In ob/ob mice, we also detected an age-dependent trend toward increased noradrenergic innervation that, unlike in db/db mice, was unrelated to glucose levels. We also observed a progressive increase in Neuropeptide Y-immunoreactive elements localized to the islet core.

conclusionsOur data show increased numbers of sympathetic nerve fibers with a potential to convey inhibitory signals on insulin secretion in pancreatic islets of genetically obese animals, regardless of their diabetic state. The findings suggest an alternative interpretation of the pathogenesis of beta cell failure, as well as novel strategies to reverse abnormalities in insulin secretion.

Indexed as

Neural InhibitionAdrenergic NeuronsAge FactorsAnimalsBlood GlucoseDiet, High-FatDisease Models, AnimalFemaleHypertrophyInsulinInsulin-Secreting CellsIslets of LangerhansMiceNeuropeptide YObesityTyrosine 3-MonooxygenaseBlood GlucoseInsulinNeuropeptide YTyrosine 3-MonooxygenaseIsletsNoradrenergic fibersObesity

Identifiers

PMID24462047
PMCPMC4082304
OpenAlexW2100515410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.